November 24, 2008 — The opioid antagonist naltrexone significantly reduces relapse in individuals addicted to amphetamines, new research suggests. A randomized, double-blind, placebo-controlled trial ...

A recent JAMA Psychiatry study found that an ADHD medicine called lisdexamfetamine reduced the risk of hospitalization due to amphetamine or methamphetamine addiciton by 18% and 14% for deaths caused ...

The ADHD medication lisdexamfetamine was associated with the lowest risk of hospitalization and death in people with amphetamine addiction, when medications generally used among persons with substance ...

Alcohol remains the most common drug forcing people into treatment, used to excess by a third of the 127,000 who sought help in 2017. The new data on alcohol and drug treatment, released today by the ...

The number of people hospitalized because of amphetamine use is skyrocketing. This is a Kaiser Health News story. The number of people hospitalized because of amphetamine use is skyrocketing in the ...

The number of people addicted to cocaine in the United States has remained relatively stable over the past several decades and ranges between 1.0 and 1.7 million (Substance Abuse and Mental Health ...

The number of people hospitalized because of amphetamine use is skyrocketing in the United States, but the resurgence of the drug has largely been overshadowed by the nation’s intense focus on opioids ...

When methadone was first proposed for the treatment of heroin addiction, it sounded like a pointless gambit — sort of like substituting vodka for gin. That’s enabling addicts, critics said, not ...

Amphetamines—variously known as speed, ice, crystal, pep pills, Benzedrine, Dexedrine, Adderall, Ritalin, and countless other brand names—have played a persistent role in the pharmaceutical ...

Chronic misuse of stimulants can result in mood swings, depression, irritability, and even psychosis. A notable case involved Amy (a pseudonym) in San Antonio, Texas. She misused Adderall, ...

The prescription use of the stimulants methylphenidate and amphetamine for the treatment of attention deficit–hyperactivity disorder (ADHD) has been increasing. In 2007, the Food and Drug ...